Performance of the new 2011 ACR/EULAR remission criteria with tocilizumab using the phase IIIb study TAMARA as an example and their comparison with traditional remission criteria

BACKGROUND: Remission is the established goal in rheumatoid arthritis (RA) treatment. Although originally defined by a disease activity score in 28 joints (DAS28) <2.6, more stringent criteria may imply the absence of disease activity. The 2011 ACR/EULAR remission criteria provide the newest and...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Iking-Konert, Christof, Aringer, Martin, Wollenhaupt, Jürgen, Mosch, Thomas, Tuerk, Stefan, Feist, Eugen, Burmester, Gerd R
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2011
Assuntos:
Clinical and Epidemiological Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3184242/
https://ncbi.nlm.nih.gov/pubmed/21875873
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2011.152678
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados